Helsinn
Helsinn is a subsidiary of global pharmaceutical company Helsinn.
Helsinn is a privately owned, self-financing pharmaceutical group with headquarters in Lugano, Switzerland and premises in Ireland and USA. The Helsinn Group has been built on the basis of a unique business model, focused on the in- and out-licensing of pharmaceuticals, with the recent additions of medical devices in therapeutic niche areas.
Financial Data
-
31st Dec 18 Source: CRO
- €161.4 million turnover
-
-€1.9 million
profit - 183 employees
-
31st Dec 17 Source: CRO
- €168.2 million turnover
-
€14.8 million
profit - 182 employees
- 7 more years available »
Ranking
By Turnover
(€161.4 million)- 366th in Top Companies
- 39th in Pharma
By Employees
(183)- 603rd in Top Companies
- 57th in Pharma
-
- 183
- €161.4 million
Employees
- Riccardo Braglia CEO/Managing Director
Latest News
- Jan 23 Fenergo on acquisition trail as revenue and headcount rises
- Jan 23 Three takes ComReg to court over plans to cap radio spectrum purchase
- Jan 22 Equities dip and oil slides as global risk rally stalls
- Jan 22 German car maker VW posts €10bn profit in spite of pandemic-ravaged year
- Jan 22 Volkswagen posts €10bn profit for 2020 after late recovery